News

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating
CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, ...
Morgan Stanley: A 7% Yield On The Preferred Shares
Morgan Stanley's Series E preferred shares offer a 7.1% yield, strong coverage, and resilience. Check out my analysis of MS ...
Morgan Stanley4d
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity ...
A team of engineers saved Morgan Stanley more than 280,000 hours this year. The bank says their tool won't take jobs.
A new tool at Morgan Stanley has saved more than 11,000 days of work this year alone and replaced "onerous" rote work.
The market will continue to grind higher over the near-term, says Morgan Stanley's Lisa Shalett
Lisa Shalett, Morgan Stanley Wealth Management CIO, joins 'Closing Bell' to discuss the record market run, why she sees more ...
Morgan Stanley Said to Tap Esteve as Equity Syndicate EMEA Head
Morgan Stanley has appointed Javier Esteve as head of equity syndicate for Europe, the Middle East and Africa, according to ...
Morgan Stanley Assumes Coverage of Axsome Therapeutics (AXSM) with an Overweight Rating
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
The 3 areas of the stock market to buy as the dollar continues to plummet, Morgan Stanley says
The dollar is dropping, but that's good news for US companies doing business overseas. Morgan Stanley says four sectors ...
Morgan Stanley Reshuffles Tech Investment Banking Leadership
Morgan Stanley has appointed Drew Guevara as a global co-head of technology investment banking as part of a broader reshuffle ...
The Financial Express13h
Reliance’s next $50 billion bet: AI-energy synergy at heart of new growth path, says Morgan Stanley
Reliance Industries is eyeing its next $50 billion in value creation by integrating green energy and AI infrastructure, with ...